Geron Says FDA Lifts Hold on Stem Cell Trial
Geron says FDA will allow embryonic stem cell study; safety concerns caused 11-month delay Stem cell – Embryonic stem cell – Biotechnology – Spinal cord injury – Geron Corporation
Geron says FDA will allow embryonic stem cell study; safety concerns caused 11-month delay Stem cell – Embryonic stem cell – Biotechnology – Spinal cord injury – Geron Corporation